Edition:
United Kingdom

Olympus Corp (7733.T)

7733.T on Tokyo Stock Exchange

4,720JPY
25 Mar 2019
Change (% chg)

¥-255 (-5.13%)
Prev Close
¥4,975
Open
¥4,855
Day's High
¥4,860
Day's Low
¥4,660
Volume
1,761,100
Avg. Vol
1,778,598
52-wk High
¥5,100
52-wk Low
¥3,035

Select another date:

Mon, Mar 11 2019

Photo

Olympus whistleblower Woodford wins London pensions lawsuit

LONDON The former CEO of Olympus, who blew the whistle on a $1.7 billion (£1.2 billion) accounting scandal at the Japanese medical equipment maker in 2011, has won a London court battle over alleged wrongdoing linked to his 64-million-pound pension.

Olympus whistleblower Woodford wins London pensions lawsuit

LONDON The former CEO of Olympus, who blew the whistle on a $1.7 billion accounting scandal at the Japanese medical equipment maker in 2011, has won a London court battle over alleged wrongdoing linked to his 64-million-pound ($85-million) pension.

Olympus whistleblower Woodford wins London pensions lawsuit

LONDON, March 11 The former CEO of Olympus , who blew the whistle on a $1.7 billion accounting scandal at the Japanese medical equipment maker in 2011, has won a London court battle over alleged wrongdoing linked to his 64-million-pound ($85-million) pension.

Japan's Olympus to propose board seat for activist investor ValueAct

TOKYO Japan's Olympus Corp said it would propose to give top shareholder U.S. hedge fund ValueAct Capital a seat at its board, a rare move in the country where activists are still viewed by companies as asset-strippers to be resisted.

Japan's Olympus to propose board seat for activist investor ValueAct

TOKYO, Jan 11 Japan's Olympus Corp said it would propose to give top shareholder U.S. hedge fund ValueAct Capital a seat at its board, a rare move in the country where activists are still viewed by companies as asset-strippers to be resisted.

Nikkei ends firmer on positive trade talks; Olympus jumps 8.4 pct

* Olympus surges after two brokerages raise their stock ratings

Nikkei gains on hopes for U.S.-China talks, Olympus leaps 7.6 pct

* Olympus jumps after two brokerages raise their stock ratings

Olympus unit pleads guilty to resolve U.S. duodenoscope probe

An Olympus Corp subsidiary pleaded guilty on Monday and agreed to pay $85 million to resolve charges that it failed to file reports with U.S. regulators regarding infections connected to its duodenoscopes while continuing to sell the medical devices used to view the gastrointestinal tract.

UPDATE 3-Olympus unit pleads guilty to resolve U.S. duodenoscope probe

Dec 10 An Olympus Corp subsidiary pleaded guilty on Monday and agreed to pay $85 million to resolve charges that it failed to file reports with U.S. regulators regarding infections connected to its duodenoscopes while continuing to sell the medical devices used to view the gastrointestinal tract.

Select another date: